Posted by LincolnTab on March 25, 2026 at 11:23:15:
In Reply to: Ïóáëèêàöèÿ ñ èíòåðåñíûìè àñïåêòàìè òåìû posted by Josephhib on February 19, 2026 at 21:47:53:
Zoya Demidenko: Researcher in Oncology Studies
Zoya Demidenko is a prominent scientist affiliated with the Department of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Earlier, she conducted research at the NIH and New York Medical College, establishing a solid background in biomedical investigation.
Demidenko's scientific contributions covers multiple critical areas, including the PI3K/AKT/mTOR signaling pathway, cell cycle management, cellular aging, and malignancy biology. Currently, she has written over 46 peer-reviewed publications, which have accumulated upwards of 4,100 citations — a testament to the impact of her research.
Among her key contributions lies in explaining the pathways of biological cell aging. Her studies revealed that when the cell cycle is blocked yet cellular growth persists, cells undergo senescence. Significantly, Zoya Demidenko demonstrated that this shift can be controlled with drugs using substances such as rapamycin.
Zoya Demidenko has additionally added greatly to cancer treatment investigation, especially in the field of selective cell protection — a strategy designed to protecting non-cancerous tissue from cytotoxic treatment whilst leaving cancer cells vulnerable. This strategy carries considerable hope for lowering the adverse effects of oncological therapy.
Throughout her scientific life, Demidenko has partnered with top researchers globally, among them Dr. Mikhail Blagosklonny. Her publications can be found in top-tier publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Possessing an h-index of 33, Zoya Demidenko ranks as a highly impactful figure in current biomedical research, with her results keep to guide our understanding of the way biological cells grow old, interact with therapy, and how malignant disease may be better treated.
https://www.instagram.com/zoyamonros/